Compounds > 1,3-bis(tris(hydroxymethyl)methylamino)propane
Page last updated: 2024-09-03

1,3-bis(tris(hydroxymethyl)methylamino)propane and famotidine

1,3-bis(tris(hydroxymethyl)methylamino)propane has been researched along with famotidine in 1 studies

Compound Research Comparison

Studies
(1,3-bis(tris(hydroxymethyl)methylamino)propane)		Trials
(1,3-bis(tris(hydroxymethyl)methylamino)propane)		Recent Studies (post-2010)
(1,3-bis(tris(hydroxymethyl)methylamino)propane)		Studies
(famotidine)		Trials
(famotidine)		Recent Studies (post-2010) (famotidine)
150463026

Protein Interaction Comparison

ProteinTaxonomy1,3-bis(tris(hydroxymethyl)methylamino)propane (IC50)famotidine (IC50)
Histamine H2 receptorHomo sapiens (human)0.042
Multidrug and toxin extrusion protein 1Homo sapiens (human)0.76

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briggs, JM; Bushman, FD; Carlson, HA; Jorgensen, WL; Lins, RD; Masukawa, KM; McCammon, JA; Rubins, K1

Other Studies

1 other study(ies) available for 1,3-bis(tris(hydroxymethyl)methylamino)propane and famotidine

ArticleYear
Developing a dynamic pharmacophore model for HIV-1 integrase.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Computer Simulation; Drug Evaluation, Preclinical; HIV Integrase; HIV Integrase Inhibitors; Models, Chemical; Models, Molecular; Protein Conformation; Structure-Activity Relationship

2000